The global gel imaging documentation market size is anticipated to be worth US$ 297.38 Mn in 2022. During the projection period of 2022 to 2032, the market is predicted to grow at a CAGR of 3.3%, with an anticipated valuation of US$ 406.47 Mn by 2032.
| Attributes | Details |
|---|---|
| Market Value (2022) | US$ 297.38 Million |
| Market Forecast Value (2032) | US$ 406.47 Billion |
| Market CAGR (2022 to 2032) | 3.3% |
Systems for recording and measuring tagged nucleic acids and proteins in various media, such as cellulose, acrylamide, or agarose, are known as gel imaging documentation. One of the main factors influencing the market is the rising incidences of chronic diseases such as heart disease, cancer, arthritis, diabetes, and Alzheimer's disease.
The industry is expanding, partly because of the growing use of polymerase chain reaction (PCR) techniques for disease diagnosis and detection. Additionally, governments in numerous nations are funding genomic, proteomic, and electrophoresis technologies, which are having a beneficial impact on the market.
The main factor impeding the market expansion of the gel imaging documentation market is the increasing utilization of quantitative polymerase chain reaction (QPCR). Nevertheless, the increasing use of advanced techniques for detecting protein from a sample, such as deoxyribonucleic acid (DNA) diagnostics and western blot, is fueling the market growth.
The digital gel imaging system has captured key market share as these devices make it easier to capture images by offering auto-exposure and auto-focusing features. The majority of these gel documentation imaging systems include software and are compatible with operating systems.
In terms of revenue share, the systems sector is most likely to dominate the global market. This is a result of rising R&D activity in medicinal and biotechnology productions. The US market for gel imaging documentation is expected to be worth around US$ 97 Mn. Well-established industries like biotechnology and pharmaceutical, as well as growing public knowledge of technological improvements, are driving the growth in the region.
In 2021, it was anticipated that the China market for gel imaging documentation would be worth US$ 32 million due to an increase in genetic and infectious illness cases, as well as an increase in molecular biology research and development. In February 2018, Syngene unveiled a new red InGenius3 gel documentation product. It has a miniature darkroom that can use ultraviolet, blue, or white lighting and contains a three-million-pixel CCD camera.
Synoptics Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., GE Healthcare, Analytik Jena AG, Azure Biosystems, Inc., Labnet International, Inc., Biobase Group, and Maestrogen are some of the major international companies functioning in the worldwide gel imaging documentation market. Thermo Fisher Scientific Inc., Synoptics Ltd., and Bio-Rad Laboratories collectively hold a significant portion of the market for gel imaging documentation globally.
Gel imaging systems, also known as gel documentation systems is a revolutionized medical equipment which performs the function of imaging, documentation or recording of stained DNA and proteinon a high tech digital platform. Gel imaging systems is a combination of different component such as an imaging system, a computer, a light source, analysis software and a printer.
For instance, G:BOX F3 is an entry level gel documentation system manufactured by Syngene fluorescence and visible applications. The systems works with GeneSys software which handles hundreds of application protocol and functional control.
The product even have high resolution camera coupled with motor driven zoom lens, which is capable of giving high quality gel images along with the spatial resolution. Many other companies are engaged in manufacturing of gel imaging systems such as Thermo Fisher Scientific, BIOTEC-FISCHER, UVP LLC, Cleaver Scientific Ltd., and Bio-Rad Laboratories, Inc.
Gel imaging technology has come a long way since its inception, where the technicians used to prefer instant cameras. It has replaced the traditional approach of gel analysis and documentation owing to its better dynamic range, faster exposure and higher efficiency.
Moreover, other tools such as signal saturation and automated features offers user friendly experience of gel documentation to new technicians. In terms of reliability, functionality, and affordability, these devices has improved enormously and today’s gel imaging equipment’s illustrate this development.
Growing clinical research industry and increasing use of molecular biology techniques into pathology laboratory practices are expected to drive the growth of gel documentation systems market. Currently, the use of advance techniques such as Western blot technique, and DNA diagnostics has increased tremendously, which in return generates need for automated and advance gel documentation systems.
Additionally, companies are also focusing on the approval and product launch of gel documentation systems owing to substantial growth in clinical research and drug development industry. Recently, Viewpoint Laboratories, LLC, has launched a new gel documentation system i.e. ZIG-gel Classic, which provides imaging power of an 18 MP, 10x optical zoom camera.
This product is expected to fulfill the need of consumer looking for the high image resolution along with the conventional form factor particularly for research labs and life science educator labs. Such ongoing product development and launch by the leading companies are expected to drive the growth of gel documentation systems market.
Development of advanced but low cost gel documentation systems will pave the road for new entrants. The upcoming research and drug development activities will open a new avenue and extraordinary opportunities for gel documentation systems manufacturing companies.
The cost of gel documentation systems is currently high owing to incorporation of advanced technologies and complex consumer’s requirements. However, many Chinese manufacturers are now coming up with the low cost and low resolution gel imaging devices. Thus, the price of these devices is expected to decrease as compared to the branded products in coming years.
Geographically, the global gel documentation system market is segmented into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding Japan, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global market for gel documentations systems market due to high demand for research and development activities.
Europe market is expected to account for second largest share in global market primarily due to high adoption of gel documentation systems which is expected to fuel the market growth. Asian companies are competing on the basis of price and research activities. Hence, the Asia Pacific gel documentation systems market is expected to witness fastest growth in overall market over the forecast period.
Key players operating in the global gel documentation systems market are Syngene, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., UVP LLC, eikonix Ltd, Viewpoint Laboratories, TBG Biotechnology Corp and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global market for gel documentation is segmented on the basis of product type, component, application and geography.
The market is likely to register a CAGR of 3.3% through 2032.
The market is currently valued at US$ 297.38 Mn in 2022.
The market is likely to grow to a valuation of US$ 406.47 Mn by 2032
North America is likely to be a leading market during the forecast period.
Explore Similar Insights
Gel Imaging Documentation Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
